Heart failure & cardiomyopathiesResearch article
Enhancing heart failure care through registries: lessons learned from Nordic Countries’ implementation of guidelines
- Narrative review
Nurse-led registry models with quality benchmarks and real-time feedback on guideline-directed medical therapy (GDMT)
Authors' conclusion
The findings underscore that HF registries play a crucial role in enhancing care quality through established drug therapies for HFrEF, offering a model for integrating data-driven methodologies into HF management.
Study context
- Population
- Patients with heart failure with reduced ejection fraction (HFrEF) in Nordic heart failure (HF) registries (Sweden, Denmark, Norway, Iceland)
- Comparison
- 2021 vs 2024
Main finding
As reported in the abstract
GDMT utilisation (registry population-weighted estimates) · 2021–2024
MRA
SGLT2 inhibitors
Sacubitril/valsartan
- Beta-blockers consistently high
- 91%
- Renin-angiotensin-system inhibitors consistently high
- 94%
Original publication
Enhancing heart failure care through registries: lessons learned from Nordic Countries’ implementation of guidelines. Eur J Heart Fail. Published 5 March 2026. doi:10.1093/ejhf/xuag060
Summarised from the published abstract; every number is checked against it